Atlas Trials

Retrospective Study on the Safety of Nivolumab in Patients With mRCC and Renal Failure

Clinical trial NCT07117409 · TERMINATED

Trial details

NCT number
NCT07117409
Sponsor
Azienda USL Reggio Emilia - IRCCS
Status
TERMINATED
Study type
OBSERVATIONAL
Metastatic Renal Cell Carcinoma
Start date
2020-06-29
Primary completion
2022-05-30
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.